2010•Chinese Heart JournalRequires access

Study on the protective effects of trimetazidine dihydrochloride on acute viral myocarditis

Jiao Li

Open publisher page 0 citations

Abstract

AIM:To explore the protective effect of trimetazidine dihydrochloride on acute viral myocarditis.METHODS:Eighty six patients with acute viral myocarditis were randomly divided into trimetazidine dihydrochloride metabolic drug treatment group(n=40) and usual routine treatment group(n=46).Patients in both groups were bedridden and were treated with antibiotics and hormones.Metabolic drug treatment group was administered trimetazidine dihydrochloride in addition to the synthetic treatment.Before and after treatment,venous blood was collected and tested including CK-MB,cTnI,ESR,hs-CRP and TNF-α.RESULTS:Levels of CK-MB,cTnI,hs-CRP and TNF-α of trimetazidine dihydrochloride treatment group were lower than levels of the routine treatment group(P0.05),but no significant difference was observed between the ESR levels of the two groups.CONCLUSIONS:Trimetazidine dihydrochloride has demonstrated a protective effect on acute viral myocarditis.

About this research paper

What this paper is about

AIM:To explore the protective effect of trimetazidine dihydrochloride on acute viral myocarditis.METHODS:Eighty six patients with acute viral myocarditis were randomly divided into trimetazidine dihydrochloride metabolic drug treatment group(n=40) and usual routine treatment group(n=46).Patients in both groups were bedridden and were treated with antibiotics and hormones.Metabolic drug treatment group was administered trimetazidine dihydrochloride in addition to the synthetic treatment.Before and after treatment,venous blood was collected and tested including CK-MB,cTnI,ESR,hs-CRP and TNF-α.RESULTS:Levels of CK-MB,cTnI,hs-CRP and TNF-α of trimetazidine dihydrochloride treatment group were lower than levels of the routine treatment group(P0.05),but no significant difference was observed between the ESR levels of the two groups.CONCLUSIONS:Trimetazidine dihydrochloride has demonstrated a protective effect on acute viral myocarditis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To explore the protective effect of trimetazidine dihydrochloride on acute viral myocarditis.METHODS:Eighty six patients with acute viral myocarditis were randomly divided into trimetazidine dihydrochloride metabolic drug treatment group(n=40) and usual routine treatment group(n=46).Patients in both groups were bedridden and were treated with antibiotics and hormones.Metabolic drug treatment group was administered trimetazidine dihydrochloride in addition to the synthetic treatment.Before and after treatment,venous blood was collected and tested including CK-MB,cTnI,ESR,hs-CRP and TNF-α.RESULTS:Levels of CK-MB,cTnI,hs-CRP and TNF-α of trimetazidine dihydrochloride treatment group were lower than levels of the routine treatment group(P0.05),but no significant difference was observed between the ESR levels of the two groups.CONCLUSIONS:Trimetazidine dihydrochloride has demonstrated a protective effect on acute viral myocarditis.

Key concepts: Trimetazidine, Viral Myocarditis, Medicine, Internal medicine, Troponin I, Myocarditis, Gastroenterology, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the protective effects of trimetazidine dihydrochloride on acute viral myocarditis — Research Paper | ScholarLens